Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

Eligibility NCT00321464 Bone Metastases in Subjects With Advanced Breast Cancer - Eligibility

- 14/04/2014 - 1 Formulário, 2 Grupos de itens, 8 Elementos de dados, 2 Idiomas

Grupos de itens: Inclusion Criteria, Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00321464

Prostate Cancer NCT00079001 On-Study - CALGB 90202: Skeletal Survey Form - 2083769v3.0 - CALGB 90202: Skeletal Survey Form

- 09/01/2015 - 1 Formulário, 1 Grupo de itens, 22 Elementos de dados, 1 Idioma

Grupo de itens: CCRR MODULE

CALGB 90202: Skeletal Survey Form Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7BE7E12-C8DF-7003-E034-0003BA12F5E7

Metastatic Cancer NCT00134056 Response - Southwest Oncology Group - Bisphosphonate Usage Form - 2759910v1.0 - Southwest Oncology Group - Bisphosphonate Usage Form

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 19 Elementos de dados, 1 Idioma

Grupos de itens: Header, Header, Comments

Southwest Oncology Group - Bisphosphonate Usage Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4FD609AB-09CA-1C94-E044-0003BA3F9857

Metastatic Cancer NCT00134056 Pre-Study - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421) - 2306139v3.0 - SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421)

- 09/01/2015 - 1 Formulário, 8 Grupos de itens, 79 Elementos de dados, 1 Idioma

Grupos de itens: Header, PATIENT AND DISEASE DESCRIPTION, Laboratory Values, Associated Correlative Science Consent, Additional Prestudy Data, DISTANT METASTATIC DISEASE, Prior Treatment Related To This Cancer, Comments

SOUTHWEST ONCOLOGY GROUP Prestudy Form (S0421) Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F1F9786C-0716-36C3-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Follow-Up - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM - 2305135v3.0 - SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 27 Elementos de dados, 1 Idioma

Grupos de itens: Header, VITAL STATUS, Comments

SOUTHWEST ONCOLOGY GROUP FOLLOW UP FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159EF7E-D486-319F-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Response - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM - 2304629v3.0 - SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 12 Elementos de dados, 1 Idioma

Grupos de itens: Header, PSA MEASUREMENTS, Comments

SOUTHWEST ONCOLOGY GROUP PROSTATIC SPECIFIC ANTIGEN REPORTING FORM Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159832A-A1FF-27F6-E034-0003BA3F9857

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases - Radium 223 Dichloride (Alpharadin) - Screening Visit

- 13/02/2017 - 1 Formulário, 9 Grupos de itens, 89 Elementos de dados, 1 Idioma

Grupos de itens: Demography, Vital Signs, Prostate Cancer Classification, BPI-SF, ECOG Performance Status, Prior radiotherapy, Prior diagnostic and therapeutic procedures for prostate cancer, Hematology (with DBC), General chemistry - Serum

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization - 2305232v3.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 20 Elementos de dados, 1 Idioma

Grupos de itens: Header, ADVERSE EVENTS, Comments

SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT FORM: Step 1 Randomization Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15B0C64-8BEB-3314-E034-0003BA3F9857

Metastatic Cancer NCT00134056 Toxicity - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form - 2464820v1.0 - SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form

- 09/01/2015 - 1 Formulário, 3 Grupos de itens, 20 Elementos de dados, 1 Idioma

Grupos de itens: Header, ADVERSE EVENTS, Comments

SOUTHWEST ONCOLOGY GROUP S0421 ADVERSE EVENT SUMMARY FORM: Step 2 Post-Chemo Form Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0F9D4F4F-BA23-2F60-E044-0003BA3F9857

Southwest Oncology Group Registration Form (S0421) NCT00134056

- 20/09/2021 - 1 Formulário, 3 Grupos de itens, 40 Elementos de dados, 1 Idioma

Grupos de itens: Header, Patient demographics, Miscellaneous Patient Information

Southwest Oncology Group Registration Form (S0421) NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F15A11DF-588A-2157-E034-0003BA3F9857

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056

- 20/09/2021 - 1 Formulário, 3 Grupos de itens, 53 Elementos de dados, 1 Idioma

Grupos de itens: Header, Randomization questions, Patient status assessment

Southwest Oncology Group S0421 FACT-P Questionnaire: Step 1 Randomization Form NCT00134056 Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F159B9D6-FD84-2C7B-E034-0003BA3F9857

Eligibility Bone Metastases NCT02226276

- 20/09/2021 - 1 Formulário, 2 Grupos de itens, 17 Elementos de dados, 1 Idioma